11.06.2013 • NewsBASFSouth AmericaCrop Protection

BASF Expands South American Crop Protection Capacity

German chemical giant BASF is investing more than €30 million in the expansion of its crop protection activities in South America, increasing local production and formulation capacity for its "latest blockbuster products." Brazil is the focal point of the investment, which includes a capacity build-up at the Guaratinguetá chemical complex, about 170 km from Sao Paulo.

By 2014, the Guaratinguetá complex will add a formulation plant for BASF's blockbuster herbicide Heat, recently approved by Brazilian authorities. Another local project is the expansion of a facility to produce the fungicide active ingredient Boscalid, expected to be completed by the end of this month. Additional plans include a formulation plant for the new fungicide Xenium, a next-generation carboxamide product, due on stream in mid-2014.

The German group's spending scheme for South America also includes a new plant for biological products to open in Chile in August of this year, adding to the portfolio of its recently established Functional Crop Care business unit.

BASF's strategy is to considerably enhance local production in the region and build on the investments it has made in recent years, said Markus Heidt, president of the crop protection division. When the new Brazilian plants are up and running, he said the group will increase its exports from the country.

 

 

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.